John L Lamattina
Director at Ligand Pharmaceuticals Inc (LGND)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 25731,303 held (−1%) | $247.22 | $64K | +22.1% |
| Jun 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 23231,071 held (−1%) | $248.11 | $58K | +21.6% |
| Jun 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 69730,374 held (−2%) | $249.53 | $174K | +21.0% |
| Jun 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 3,40526,969 held (−11%) | $251.62 | $857K | +19.9% |
| Mar 31SEC | LGNDLigand Pharmaceuticals Inc | Sell | 2,16130,724 held (−7%) | $200.76 | $434K | +50.3% |
| Nov 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 2,14530,724 held (−7%) | $205.45 | $441K | +46.9% |
| Nov 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 2,03430,724 held (−6%) | $205.45 | $418K | +46.9% |